Filter
829
Filtered Results: 829
Text search:
European
Monitoring
Centre
for
Drugs
and
Drug
Addiction
Featured
Recommendations
73
New Publications
163
Language
Document type
No document type
498
Studies & Reports
146
Guidelines
106
Manuals
39
Strategic & Response Plan
19
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
3
Countries / Regions
Western and Central Europe
69
Eastern Europe
31
Global
28
Ukraine
24
India
23
Sierra Leone
15
Kenya
15
Africa
14
Nepal
12
Zambia
12
Ghana
11
Russia
11
Nigeria
10
Uganda
10
Eastern Europe and Central Asia
10
Ethiopia
8
Myanmar / Burma
8
Albania
8
Cambodia
7
South Africa
7
Tajikistan
7
Liberia
6
Tanzania
6
Namibia
6
Latin America and the Carribbean
6
Asia
6
Burkina Faso
5
Rwanda
5
Bangladesh
5
Malawi
5
West and Central Africa
5
South–East Asia Region
5
Georgia
5
Senegal
4
Philippines
4
Syria
4
Laos
4
Moldova
4
Congo, Democratic Republic of
3
Zimbabwe
3
Pakistan
3
Jordan
3
Germany
3
Thailand
3
North Macedonia
3
Lesotho
3
East and Southern Africa
3
Morocco
2
South Sudan
2
Lebanon
2
Indonesia
2
Mozambique
2
Eswatini/ Swaziland
2
Botswana
2
Sri Lanka
2
Middle East and North Africa
2
Estonia
2
Kyrgyzstan
2
Vietnam
2
Guinea
1
USA
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Afghanistan
1
Turkey
1
Ireland
1
Sudan
1
Benin
1
Argentina
1
Brazil
1
Serbia
1
Hungary
1
Colombia
1
Greece
1
Mexico
1
Western Pacific Region
1
Fiji
1
Bhutan
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Lithuania
1
Iran
1
Uzbekistan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Tunisia
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
89
Public Health
46
Women & Child Health
24
Key Resources
15
Pharmacy & Technologies
15
Capacity Building
6
Toolboxes
HIV
153
Mental Health
120
TB
103
AMR
68
Pharmacy
38
COVID-19
23
Rapid Response
19
Refugee
15
NCDs
15
Global Health Education
13
Conflict
12
Ebola
10
NTDs
10
Planetary Health
9
Disability
7
Caregiver
6
Polio
4
Specific Hazards
3
Health Financing Toolbox
3
Natural Hazards
1
Zika
1
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-incr...
A survey of prevention, testing and treatment policies and practices
Perspectives sur les drogues
Perspectivas sobre las drogas
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May ... June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA team interviewed more than120 individuals from approximately 78 organizations, including the government of Senegal (GOS), donors, USAID implementing partners, private sector umbrella organizations, private insurance companies, faith-based organizations (FBOs), nongovernmental organizations (NGOs), private health care facilities, and private pharmacies.
Through stakeholder interviews and review of government reports and online resources, the assessment team noted the following findings by theme.
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety <... efficacy.
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled i...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- ... middle-income countries (LMICs), where access to antibiotics has risen with increases in gross domestic product per capita. Per capita antibiotic consumption in LMICs is lower than in high-income countries, despite a higher infectious disease burden; however, consumption rates are rapidly converging. These trends reflect both better access to antibiotics for those who need them and increases in inappropriate antibiotic use.
Copenhagen, Denmark, 24–25 August 2017
An Independent Report
of the West Africa Commission on Drugs
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
AIDSTAR-One | CASE STUDY SERIES November 2012
Copenhagen, Denmark, 7–8 March 2017. Meeting report
